Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierluigi Viale

Showing results (171-180 of 466) with videos related to

Pageof 47
Sort By:
The Journal of Antimicrobial Chemotherapy|March 24, 2025
A pre-post quasi-experimental study of the impact of TDM-guided aggressive pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftolozane/tazobactam monotherapy in treating severe Pseudomonas aeruginosa infections: a strategy useful for raising the bar?Milo Gatti, Matteo Rinaldi, Cecilia Bonazzetti, et al.
Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association|December 5, 2020
White Blood Cell Count Is the Most Reliable Test for the Diagnosis of Septic Arthritis After Anterior Cruciate Ligament Reconstruction: An Observational Study of 38 PatientsGiuseppe Gianluca Costa, Alberto Grassi, Mirco Lo Presti, et al.
Biochemical and Biophysical Research Communications|September 28, 2010
HIV-1 Tat protein enhances RANKL/M-CSF-mediated osteoclast differentiationDavide Gibellini, Elisa De Crignis, Cristina Ponti, et al.
Annals of the New York Academy of Sciences|November 23, 2006
Human granulocytic anaplasmosis in northeastern ItalyAnna Beltrame, Maurizio Ruscio, Alessandra Arzese, et al.
Antimicrobial Agents and Chemotherapy|October 29, 2025
Keeping the horse with the cart: are we underdosing tazobactam even when using continuous-infusion ceftolozane/tazobactam for effectively preventing resistance development by ESBL-producing Enterobacterales?Manjunath P Pai, Pier Giorgio Cojutti, Milo Gatti, et al.
International Journal of Antimicrobial Agents|March 6, 2023
A descriptive case series of the relationship between maintenance of conservative PK/PD efficacy thresholds of dalbavancin over time and clinical outcome in long-term treatment of staphylococcal osteoarticular infectionsMilo Gatti, Pierluigi Viale, Pier Giorgio Cojutti, et al.
Antibiotics (Basel, Switzerland)|February 26, 2025
Could a Reduced Dose of 8 g of Continuous Infusion Fosfomycin Be Considered as Effective as and Safer than a Standard 16 g Dose When Combined with High-Dose Daptomycin in the Treatment of <i>Staphylococcal osteoarticular</i> Infections?Pier Giorgio Cojutti, Sara Tedeschi, Eleonora Zamparini, et al.
Antimicrobial Agents and Chemotherapy|February 23, 2021
Population pharmacokinetics and Monte Carlo simulation for dosage optimization of fosfomycin in the treatment of osteoarticular infections in patients without renal dysfunctionMatteo Rinaldi, Pier Giorgio Cojutti, Eleonora Zamparini, et al.
Frontiers in Neurology|September 4, 2023
Healthcare-associated infections and antimicrobial resistance in severe acquired brain injury: a retrospective multicenter studyGiovanna Barbara Castellani, Elisa Maietti, Gloria Leonardi, et al.
In Vivo (Athens, Greece)|June 23, 2022
A Case Report of Tolvaptan Therapy for ADPKD Patients With COVID-19. The Need for Appropriate Counselling for Temporary Drug DiscontinuationIrene Capelli, Francesca Iacovella, Laura Ghedini, et al.
Pageof 47

Showing results (171-180 of 466) with videos related to

Sort By:
Pageof 47
The Journal of Antimicrobial Chemotherapy|March 24, 2025
A pre-post quasi-experimental study of the impact of TDM-guided aggressive pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftolozane/tazobactam monotherapy in treating severe Pseudomonas aeruginosa infections: a strategy useful for raising the bar?Milo Gatti, Matteo Rinaldi, Cecilia Bonazzetti, et al.
Arthroscopy : the Journal of Arthroscopic & Related Surgery : Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association|December 5, 2020
White Blood Cell Count Is the Most Reliable Test for the Diagnosis of Septic Arthritis After Anterior Cruciate Ligament Reconstruction: An Observational Study of 38 PatientsGiuseppe Gianluca Costa, Alberto Grassi, Mirco Lo Presti, et al.
Biochemical and Biophysical Research Communications|September 28, 2010
HIV-1 Tat protein enhances RANKL/M-CSF-mediated osteoclast differentiationDavide Gibellini, Elisa De Crignis, Cristina Ponti, et al.
Annals of the New York Academy of Sciences|November 23, 2006
Human granulocytic anaplasmosis in northeastern ItalyAnna Beltrame, Maurizio Ruscio, Alessandra Arzese, et al.
Antimicrobial Agents and Chemotherapy|October 29, 2025
Keeping the horse with the cart: are we underdosing tazobactam even when using continuous-infusion ceftolozane/tazobactam for effectively preventing resistance development by ESBL-producing Enterobacterales?Manjunath P Pai, Pier Giorgio Cojutti, Milo Gatti, et al.
International Journal of Antimicrobial Agents|March 6, 2023
A descriptive case series of the relationship between maintenance of conservative PK/PD efficacy thresholds of dalbavancin over time and clinical outcome in long-term treatment of staphylococcal osteoarticular infectionsMilo Gatti, Pierluigi Viale, Pier Giorgio Cojutti, et al.
Antibiotics (Basel, Switzerland)|February 26, 2025
Could a Reduced Dose of 8 g of Continuous Infusion Fosfomycin Be Considered as Effective as and Safer than a Standard 16 g Dose When Combined with High-Dose Daptomycin in the Treatment of <i>Staphylococcal osteoarticular</i> Infections?Pier Giorgio Cojutti, Sara Tedeschi, Eleonora Zamparini, et al.
Antimicrobial Agents and Chemotherapy|February 23, 2021
Population pharmacokinetics and Monte Carlo simulation for dosage optimization of fosfomycin in the treatment of osteoarticular infections in patients without renal dysfunctionMatteo Rinaldi, Pier Giorgio Cojutti, Eleonora Zamparini, et al.
Frontiers in Neurology|September 4, 2023
Healthcare-associated infections and antimicrobial resistance in severe acquired brain injury: a retrospective multicenter studyGiovanna Barbara Castellani, Elisa Maietti, Gloria Leonardi, et al.
In Vivo (Athens, Greece)|June 23, 2022
A Case Report of Tolvaptan Therapy for ADPKD Patients With COVID-19. The Need for Appropriate Counselling for Temporary Drug DiscontinuationIrene Capelli, Francesca Iacovella, Laura Ghedini, et al.
Pageof 47